A faster, more effective approach to developing nanobody therapies that prevent or treat viral infection

PREPARING FOR EMERGING VIRUSES — Sandia researchers, from left, Christine Thatcher, Jennifer Schwedler, Yooli Kim Light, Peter McIlroy and Brooke Harmon have developed a new process of screening for nanobodies that “neutralize” or disable the virus. This process represents a faster, more effective approach to developing nanobody therapies that prevent or treat viral infection.

Sandia research defends against COVID-19, prepares for future pandemics

Researchers at Sandia have created a platform for discovering, designing and engineering novel antibody countermeasures for emerging viruses. This new process of screening for nanobodies that “neutralize” or disable the virus represents a faster, more effective approach to developing nanobody therapies that prevent or treat viral infection.

Traditionally used to treat a variety of conditions, including cancer and autoimmune and inflammatory diseases, nanobodies are smaller components of conventional antibodies — a vital element of the body’s immune system that defends against disease-causing viruses or bacteria.

After screening a large, diverse library of synthetic nanobodies, Sandia researchers identified and evaluated several potent nanobodies that can protect against COVID-19. The scientists now aim to replicate this method to defend against current and future biological threats.

“The coronavirus pandemic has made evident the need for a broad range of preventive and therapeutic strategies to control diseases associated with novel viruses,” said Craig Tewell, director of Sandia’s Chemical, Biological, Radiological and Nuclear Defense and Energy Technologies Center.

With a rich history of biodefense research, Sandia helps protect the nation and the world from threats presented by bioterrorism and naturally occurring diseases, Craig said.

“With a deep understanding of how infectious disease develops and spreads, as well as how the immune system defends from infection,” Craig said, “our researchers are in a unique position to advance the creation of a wide array of disease-fighting tools, including nanobodies.”

Virologist Brooke Harmon leads Sandia’s nanobody research, a new and growing area of bioscience.

“Vaccines are very good at preventing infection, but they can take a long time to be developed and move through the regulatory process,” Brooke said. “We saw a critical need to create effective therapies that can be rapidly developed and deployed.”

Once the protein sequence, or genetic coding, of a virus has been identified, Sandia researchers have shown they can produce a nanobody-based countermeasure within 90 days. The method has not yet been tested on humans. Speeding up the discovery of neutralizing antibodies could reduce the impact of future viral outbreaks.

“Under current practice, virologists rely upon patients’ blood samples to build an antibody library that we can then screen for potential treatments. This means we have to wait, either for people to become infected or for those who are vaccinated to build an immune response,” Brooke said. “Sandia’s new method is more forward-thinking. Because we have already built a highly diverse, proprietary library, we can begin to screen for extremely potent neutralizing nanobodies as soon as the genetic coding of a virus has been identified.”

Nanobodies’ diverse attributes

Neutralizing nanobodies represents an attractive strategy, Brooke said, due to their ability to work effectively against an entire family of viruses or variants.

“We can take advantage of the fact that virus families tend to interact with immune response in the same way,” Brooke said. “This makes our treatments rapidly adaptable to all variants of a virus.”

Nanobodies are modular, meaning they can be combined with other nanobodies to increase their ability to bind to the virus or target specific tissues. Nanobodies can also be produced as smaller versions of conventional antibodies with the ability to engage the immune response.

Additionally, due to the small size of the nanobodies, they can be released into the blood and penetrate tissues more thoroughly than conventional antibodies. Nanobody therapies can also target an infection site directly, decreasing the dose needed and increasing efficacy.

Nanobodies can also be administered via aerosol, so they can be given to a patient orally or in an inhalable form. Conventional antibody treatments are less versatile and must be received through injection only.

“All of these qualities and features of nanobodies make nanobody therapies more effective than current solutions. These treatments are also easier and cheaper to manufacture,” Brooke said, “making Sandia’s method for developing and characterizing novel neutralizing antibodies an invaluable addition to the toolset for combatting the COVID-19 pandemic and future health crises.”

National recognition

Sandia’s research on nanobodies for emerging viruses received national recognition in October as a recipient of a 2021 R&D 100 Award, which honors the 100 most technologically significant products and advancements in the past year.

This research also received acclamation at the 2021 National Lab Accelerator Pitch Event, where scientists present seasoned investors with business model ideas based on innovations at the DOE laboratories. A video of Sandia’s presentation at the event can be viewed here.

One role of the national laboratories is to develop innovative technologies and commercialize the underlying intellectual property through licensing agreements with companies. The labs also engage the expertise of industry and academia to further develop technology using cooperative research and development agreements. Sandia is currently exploring multiple opportunities for licensing this research and partnering with others in the bio and chemical defense, diagnostics and medical research fields.

Original Article: Neutralizing antibodies for emerging viruses

More from: Sandia National Laboratories

Go deeper with Bing News on:

Nanobody therapies

Occupational Therapy Assistant
Occupational therapy assistants help people facing physical or mental challenges gain or regain the skills necessary for their highest quality of life. This can involve everything from daily tasks ...
The Best Light Therapy Lamps
But fortunately, it can be combated with the use of a light therapy lamp. When the days get shorter and darker, we get less exposure to natural sunlight. Doctors believe that the lack of ...
Innovative approach opens the door to COVID nanobody therapies
For COVID, the long-term goal is that techniques such as these will lower the bar for entry into nanobody research and ultimately produce therapies that prevent infection. "How we'd make the ...
Innovative approach opens the door to COVID nanobody therapies
"The method is not ours," Cross clarifies. "But we made it simpler." Toward Nanobody Therapy The relatively simple and low-cost procedure described in the paper could empower laboratories in low ...
The second age of psychedelic therapies for mental health
There’s no question that a next generation is needed. But it’s not like flipping a switch: These therapies involve a novel administration paradigm, acceptance by regulatory bodies, and public ...

Go deeper with Google Headlines on:

Nanobody therapies

[google_news title=”” keyword=”nanobody therapies” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

Go deeper with Bing News on:

Neutralizing nanobodies

Neutralizing Intel’s Management Engine
Five or so years ago, Intel rolled out something horrible. Intel’s Management Engine (ME) is a completely separate computing environment running on Intel chipsets that has access to everything ...
Neutralizing Contention: A New Policy for Taiping Island and the South China Sea
One first step would be to neutralize Taiping Island (Itu Aba, 太平島). This article explores the rationale for adopting this policy course, the necessary steps that must be taken to achieve ...
ISW: Prigozhin speculates there is Kremlin conspiracy to undermine, 'neutralize' Wagner Group
Wagner Group founder Yevgeny Prigozhin claimed he received a press question exposing a plot spearheaded by Russian dictator Vladimir Putin and Russian Security Council Secretary to undermine and ...
New therapy for prevention and treatment of COVID-19
A new treatment neutralizes the virus without relying on the patient's own immune system, potentially helping immunocompromised patients.
Neutralizing Negative Thoughts
How do you feel after consuming heavy, unhealthy food in large quantities? Do you feel bloated, sick or tired? Does it take you a few hours, even days, to feel light and energized again? Do you ...